Evidence map›Paper›PMID 31234267›Full record

ArticleInternational journal of molecular sciences2019

An Engineered Hybrid Protein from

Dalgys Martínez, Marlon Munera, Jose Fernando Cantillo, Judith Wortmann, Josefina Zakzuk, Walter Keller, Luis Caraballo, Leonardo Puerta

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Identification and Physicochemical Characterization of a New Allergen fromInternational journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dalgys MartínezInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. dmartinezdelaossa@unicartagena.edu.co.
Marlon MuneraInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. marmunera@unicartagena.edu.co.
Jose Fernando CantilloInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. josefcantillo@gmail.com.
Judith WortmannDivision of Structural Biology, Institute of Molecular Biosciences, BioTechMed, University of Graz, 8036 Graz, Austria. judith.wortmann@uni-graz.at.
Josefina ZakzukInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. jzakzuks@unicartagena.edu.co.ORCID 0000-0002-6007-5376
Walter KellerDivision of Structural Biology, Institute of Molecular Biosciences, BioTechMed, University of Graz, 8036 Graz, Austria. walter.keller@uni-graz.at.ORCID 0000-0002-2261-958X
Luis CaraballoInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. lcaraballog@unicartagena.edu.co.
Leonardo PuertaInstitute for Immunological Research, University of Cartagena, Cartagena 130000, Colombia. lpuertal1@unicartagena.edu.co.ORCID 0000-0003-2246-9697
University of Cartagena · COUniversity of Graz · AT

Funding

Autrian Science Fund (FWF). F4604COLCIENCIAS and University of Cartagena, Colombia 385-2009, 588-2013
6 · The paper itself

Abstract

The house dust mite (HDM)

Indexed as

AllergensAnimalsAntigens, DermatophagoidesDermatophagoides pteronyssinusFemaleHumansHypersensitivityImmunizationMiceMice, Inbred BALB CProtein EngineeringRecombinant ProteinsVaccines, SyntheticAllergensAntigens, DermatophagoidesRecombinant ProteinsVaccines, Syntheticallergen immunotherapyallergyhybrid proteinIgErecombinant allergen

Identifiers

PMID31234267
PMCPMC6628193
OpenAlexW2951274516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.